2. Gene
  3. Dars - aspartyl-tRNA synthetase Gene

Dars - aspartyl-tRNA synthetase Gene

  • 基因
  • 蛋白
  • 相关产品

种属: Mus musculus

同用名: Dars1; 5730439G15Rik

基因 ID: 226414 | 基因类型: protein coding

关于 Dars

功能概要

Predicted to enable RNA binding activity and aspartate-tRNA Ligase activity. Predicted to be involved in aspartyl-tRNA aminoacylation. Predicted to act upstream of or within translation. Located in cytoplasm and synapse. Part of Aminoacyl-tRNA Synthetase multienzyme complex. Is expressed in several structures, including alimentary system; brain; genitourinary system; respiratory system; and sensory organ. Orthologous to human DARS1 (aspartyl-tRNA synthetase 1). [provided by Alliance of Genome Resources, Apr 2022]

Dars 基因产物(2)

mRNA Protein Name
NM_145507.2 NP_663482.2 aspartate--tRNA ligase, cytoplasmic isoform 2
NM_177445.5 NP_803228.2 aspartate--tRNA ligase, cytoplasmic isoform 1
基因本体论
  • 细胞组分
细胞组分 GO 注释 逻辑证据 参考文献 来源
part of aminoacyl-tRNA synthetase multienzyme complex IDA
IDA: 通过直接分析推断
12060739 MGI
located in cytoplasm IDA
IDA: 通过直接分析推断
27816769 MGI
located in synapse IDA
IDA: 通过直接分析推断
27816769 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

aspartate--tRNA ligase, cytoplasmic

aspRS

aspartyl-tRNA synthetase, cytoplasmic

相关产品

Approval
生物活性分子 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-10122 Silodosin Antagonist 99.89% 是
Clinical Phase
生物活性分子 (2)
目录号 产品名 作用方式
纯度 Phase
HY-101299B Dihydrexidine hydrochloride Agonist 98.89% Phase 1
HY-101299A Dihydrexidine Agonist / Phase 1
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 Phase
HY-P99542 Tusamitamab ravtansine Inhibitor 99.04% Phase 3
HY-P99829 Cofetuzumab pelidotin Inhibitor 99.67% Phase 1
Pre-clinical Phase
生物活性分子 (21)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-164152A ADC Control Human IgG1-Deruxtecan (DAR 8) Inhibitor 97.26% 否
HY-145448 MC-VC-PABC-amide-PEG1-CH2-CC-885 99.93% 否
HY-100554 BMY 7378 99.92% 否
HY-101300 Cirazoline hydrochloride Agonist 99.56% 否
HY-RS03533 DARS2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-101299 (+)-Dihydrexidine hydrochloride Agonist / 否
HY-136884 DAR-4M 98.9% 否
HY-175504 MLS6357 Antagonist / 否
HY-RS03532 DARS1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-116982 BMY 7378 free base / 否
HY-118260 Phendioxan / 否
HY-120473 TAK-259 Antagonist / 否
HY-148252 ADRA1D receptor antagonist 1 free base Antagonist / 否
HY-156299 NMS-P945 / 否
HY-161901 BC-1293 Inhibitor / 否
HY-175669 ANO1-IN-5 Inhibitor / 否
HY-10122S Silodosin-d4 Antagonist / 否
HY-RS20900 Dars1 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21545 Dars2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27417 Dars1 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS28063 Dars2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
抗体抑制剂 (2)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-164152 ADC Control Human IgG1-Deruxtecan (DAR 4) Inhibitor 95.61% 否
HY-141599 Camidanlumab tesirine Inhibitor 96.52% 否
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z